$288.24
-6.59-2.24%
Last update: Nov 5, 7:54 PM
AbbVie Inc (ABBV) Stock Price, Quote, News & History
ABBVNYSE
AbbVie shares fell 2% despite Q3 revenue and EPS beats; analysts raised targets, citing immunology strength and long-term growth prospects.
You can purchase shares of AbbVie (NYSE:ABBV) through any online brokerage.
Other companies in AbbVie’s space includes: Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX), Moderna Inc (NASDAQ:MRNA) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
AbbVie has a consensus price target of $293.35.
The stock price for AbbVie (NYSE: ABBV) is $287.94 last updated November 5, 2026 at 7:54 PM EST.
There are no upcoming dividends for AbbVie.
AbbVie does not have any upcoming earnings scheduled.
There is no upcoming split for AbbVie.
AbbVie is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several...
